Dear Dr Wollaston,
Further to my previous communications with you regarding the matter of a secure and acceptable UK price for Liothyronine, I have today come across another disturbing report in The Times newspaper.
Please see attached. (Sent all three of Billy Kenber's reports)
Contrary to AMCo'S response liothyronine is not difficult to manufacture and is now a generic product.
Custom Pharmaceuticals, a contract manufacturing company, I believe, manufactures liothyronine for AMCo an equity company. AMCo's comments regarding mainstream Pharma companies no longer want to manufacture these products could be true. If this proves to be the case why are the NHS drug procurement dept. not being proactive and securing a supply contract with a CONTRACT pharmacuetical manufacturing company, this is not difficult to do. In fact I used to do this myself. This would remove third party profiteering and dramtically reduce the NHS drugs bill. Makes perfect sense to me.